← Leaderboards
Robert H Eckel
University Of Colorado Denver
$10,073,870
Attributed
$10,773,749
Total exposure
29
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $568.8K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$10,773,749 · 29
By mechanism
R01$5,863,635 · 4
M01$1,948,125 · 11
T32$1,239,509 · 1
R21$855,250 · 2
P30$733,230 · 1
R13$134,000 · 10
Top collaborators
- James O Hill5 shared
- Kimberley D Bruce2 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kimberley D Bruce$3,189,376
- Rachael E Van Pelt$4,639,568
- Kalen Ray Dionne$102,899
- John David Beckham$3,995,571
- Firouz Daneshgari$10,050,590
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchObesityHuman SubjectLipoprotein LipaseTriglyceridesNutrition Related TagMetabolismLipid MetabolismAdipose TissueLipidsCardiovascular DiseasesInsulin Sensitivity /ResistanceGene ExpressionBody CompositionInsightDietary LipidHmg Coa ReductasesResearch PersonnelHydrolysisProgramsAtherosclerosisLipoproteinsDiabetes MellitusBioenergetics
Grant awards (71)
Microglial Lipoprotein Lipase; a novel therapeutic Target for Alzheimer's disease$194,375
R21 · FY2020 · AG · contact PI
Microglial Lipoprotein Lipase; a novel therapeutic Target for Alzheimer's disease$233,250
R21 · FY2019 · AG · contact PI
Exploring the role of microglial lipoprotein lipase in remyelination and repair$194,375
R21 · FY2019 · NS · contact PI
2019 Kern Lipid Conference$15,000
R13 · FY2019 · DK · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$267,376
T32 · FY2018 · HL · contact PI
Exploring the role of microglial lipoprotein lipase in remyelination and repair$233,250
R21 · FY2018 · NS · contact PI
2018 Kern Lipid Conference$19,500
R13 · FY2018 · HL · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$277,979
T32 · FY2017 · HL · contact PI
2017 Kern Lipid Conference$10,000
R13 · FY2017 · HL · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$5,460
T32 · FY2017 · HL · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$280,675
T32 · FY2016 · HL · contact PI
2016 Kern Lipid Conference$10,000
R13 · FY2016 · HL · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$272,272
T32 · FY2015 · HL · contact PI
2015 Kern Lipid Conference$10,000
R13 · FY2015 · HL · contact PI
Mechanisms of Obesity in Mice with Neuron-Specific Lipoprotein Lipase Deficiency$433,055
R01 · FY2014 · DK · contact PI
Obesity and Cardiovascular Disease: Opportunity for Post-Doctoral Training$135,747
T32 · FY2014 · HL · contact PI
Mechanisms of Obesity in Mice with Neuron-Specific Lipoprotein Lipase Deficiency$416,335
R01 · FY2013 · DK · contact PI
Mechanisms of Obesity in Mice with Neuron-Specific Lipoprotein Lipase Deficiency$420,440
R01 · FY2012 · DK · contact PI
2012 Kern Lipid Conference$15,000
R13 · FY2012 · HL · contact PI
Mechanisms of Obesity in Mice with Neuron-Specific Lipoprotein Lipase Deficiency$491,166
R01 · FY2011 · DK · contact PI
2010 Kern Aspen Lipid Conference$15,000
R13 · FY2010 · HL · contact PI
2009 Kern Aspen Lipid Conference$12,500
R13 · FY2009 · HL · contact PI
2008 Kern Aspen Lipid Conference$15,000
R13 · FY2008 · HL · contact PI
MECHANISMS DEFENDING FAT MASS IN HUMANS AFTER LIPECTOMY$11,984
M01 · FY2008 · RR · contact PI
Mechanisms Defending Fat Mass in Human after Lipectomy$331,348
R01 · FY2007 · DK · contact PI
MECHANISMS DEFENDING FAT MASS IN HUMANS AFTER LIPECTOMY$101,996
M01 · FY2007 · RR · contact PI
Mechanisms Defending Fat Mass in Human after Lipectomy$353,075
R01 · FY2006 · DK · contact PI
MECHANISMS DEFENDING FAT MASS IN HUMANS AFTER LIPECTOMY$78,597
M01 · FY2006 · RR · contact PI
ASSESS CHANGES IN MEMBRANE LIPID COMPOSITION ON A HIGH PROTEIN, LOW CARB DIET$25,684
M01 · FY2006 · RR · contact PI
ASSESS CARDIOVASCULAR RISK ON A HIGH PROTEIN, LOW CARB DIET COMP W/USDA DIET$25,064
M01 · FY2006 · RR · contact PI
Mechanisms Defending Fat Mass in Human after Lipectomy$350,807
R01 · FY2005 · DK
MECHANISMS DEFENDING FAT MASS IN HUMANS AFTER LIPECTOMY$25,735
M01 · FY2005 · RR
HMG CO-A REDUCTASE INHIBITORS ON C-REACTIVE PROTEIN IN PTS W/TYPE2 DIABETES$12,582
M01 · FY2005 · RR
Mechanisms Defending Fat Mass in Human after Lipectomy$356,908
R01 · FY2004 · DK
Tissue Specific Regulation of Lipoprotein Lipase$334,635
R01 · FY2004 · DK
HMG Co-A Reductase Inhibitors on C-Reactive Protein$75,475
M01 · FY2004 · RR
Mechanisms Defending Fat Mass in Humans After Lipectomy$608
M01 · FY2004 · RR
Mechanisms Defending Fat Mass in Human after Lipectomy$358,441
R01 · FY2003 · DK
Tissue Specific Regulation of Lipoprotein Lipase$324,924
R01 · FY2003 · DK
LIPOPROTEIN LIPASE, NUTRITION AND NERVE MYELINATION$57,094
R01 · FY2003 · DK
Tissue Specific Regulation of Lipoprotein Lipase$315,497
R01 · FY2002 · DK
LIPOPROTEIN LIPASE, NUTRITION AND NERVE MYELINATION$287,756
R01 · FY2002 · DK
EFFECTS OF MAINTAINED WEIGHT LOSS IN SEVERELY OBESE HUMANS--SLEEP DYNAMICS$190,747
M01 · FY2002 · RR
TRIGLYCERIDE LOWERING IN HYPERTRIGLYCERIDEMIA$190,747
M01 · FY2002 · RR
LIPOPROTEIN LIPASE RESPONSE TO MEALS AS A PREDICTOR OF WEIGHT GAIN$190,747
M01 · FY2002 · RR
HMG CO-A REDUCTASE INHIBITORS AND C-REACTIVE PROTEIN$190,747
M01 · FY2002 · RR
CORE--METABOLIC LABORATORY$131,614
P30 · FY2002 · DK
Kern Aspen Lipid Conference 2002$12,000
R13 · FY2002 · DK
Tissue Specific Regulation of Lipoprotein Lipase$357,985
R01 · FY2001 · DK
LIPOPROTEIN LIPASE, NUTRITION AND NERVE MYELINATION$284,707
R01 · FY2001 · DK
CORE--METABOLIC LABORATORY$235,001
P30 · FY2001 · DK
LIPOPROTEIN LIPASE RESPONSE TO MEALS AS A PREDICTOR OF WEIGHT GAIN$190,747
M01 · FY2001 · RR
HMG CO-A REDUCTASE INHIBITORS AND C-REACTIVE PROTEIN$190,747
M01 · FY2001 · RR
TRIGLYCERIDE LOWERING IN HYPERTRIGLYCERIDEMIA$190,747
M01 · FY2001 · RR
EFFECTS OF MAINTAINED WEIGHT LOSS IN SEVERELY OBESE HUMANS--SLEEP DYNAMICS$190,747
M01 · FY2001 · RR
CORE--METABOLIC LABORATORY$131,614
P30 · FY2001 · DK
TISSUE SPECIFIC REGULATION OF LIPOPROTEIN LIPASE$105,549
R01 · FY2001 · DK
LIPOPROTEIN LIPASE RESPONSE TO MEALS AS A PREDICTOR OF WEIGHT GAIN$0
M01 · FY2001 · RR
EFFECTS OF MAINTAINED WEIGHT LOSS IN SEVERELY OBESE HUMANS--SLEEP DYNAMICS$0
M01 · FY2001 · RR
TRIGLYCERIDE LOWERING IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2001 · RR
HMG CO-A REDUCTASE INHIBITORS AND C-REACTIVE PROTEIN$0
M01 · FY2001 · RR
LIPOPROTEIN LIPASE, NUTRITION AND NERVE MYELINATION$283,913
R01 · FY2000 · DK
CORE--METABOLIC LABORATORY$235,001
P30 · FY2000 · DK
LIPOPROTEIN LIPASE RESPONSE TO MEALS AS A PREDICTOR OF WEIGHT GAIN$32,212
M01 · FY2000 · RR
EFFECTS OF MAINTAINED WEIGHT LOSS IN SEVERELY OBESE HUMANS--SLEEP DYNAMICS$32,212
M01 · FY2000 · RR
HMG CO-A REDUCTASE INHIBITORS AND C-REACTIVE PROTEIN$0
M01 · FY2000 · RR
TRIGLYCERIDE LOWERING IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2000 · RR
TRIGLYCERIDE LOWERING IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2000 · RR
LIPOPROTEIN LIPASE RESPONSE TO MEALS AS A PREDICTOR OF WEIGHT GAIN$0
M01 · FY2000 · RR
EFFECTS OF MAINTAINED WEIGHT LOSS IN SEVERELY OBESE HUMANS--SLEEP DYNAMICS$0
M01 · FY2000 · RR
HMG CO-A REDUCTASE INHIBITORS AND C-REACTIVE PROTEIN$0
M01 · FY2000 · RR